about
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuumConcise review: The Piwi-piRNA axis: pivotal beyond transposon silencingNon-invasive in vivo imaging of tumor-associated CD133/promininBreast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonistFlow Cytometry: Impact on Early Drug DiscoveryMolecular integrity and global gene expression of breast and lung cancer stem cells under long-term storage and recoveryviSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia.Genome and transcriptome profiles of CD133-positive colorectal cancer cells.Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control."Bad Luck Mutations": DNA Mutations Are not the Whole Answer to Understanding Cancer Risk.Distinct EMT programs control normal mammary stem cells and tumour-initiating cells.CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenationAre cancer stem cells radioresistant?The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cellsMammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherin.Stem cells and reproduction.CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity.On the path to translation: Highlights from the 2010 Canadian Conference on Ovarian Cancer Research.Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.The crossroads between cancer stem cells and aging.Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ERα- breast cancer.Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells.Caffeic Acid Phenethyl Ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cells.Bub1 is required for maintaining cancer stem cells in breast cancer cell linesHuman papillomavirus infections and cancer stem cells of tumors from the uterine cervix.Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.Mechanisms of chemoresistance in cancer stem cells.Wortmannin efficiently suppresses the recovery from radiation-induced damage in pimonidazole-unlabeled quiescent tumor cell population.The hallmarks of premalignant conditions: a molecular basis for cancer preventionRadiosensitivity of pimonidazole-unlabelled intratumour quiescent cell population to γ-rays, accelerated carbon ion beams and boron neutron capture reactionAn integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation.High frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer.Therapeutic targeting of the p53 pathway in cancer stem cells.A Tumor initiating cell-enriched prognostic signature for HER2+:ERα- breast cancer; rationale, new features, controversies and future directionsTriple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ-secretase inhibitor drug responses.Insulin Resistance and Inflammation in Black Women with and without Breast Cancer: Cause for Concern.Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits.
P2860
Q24594356-4EF6F9A7-64B6-4199-B021-7E1AED9D71A8Q26824060-86880494-9AD0-4EF0-AAD7-070CDCFC38D0Q27438105-C0EA5425-8103-4308-9663-25EB72AD7F65Q28475994-CBE0574D-7429-4433-A020-6D621BA93316Q30380311-FEA3645C-E362-4E91-86A7-0677D934AA2FQ30454378-17328C4D-E29F-4038-A488-C239F382CA3BQ30628090-FB11FBE7-83E4-4314-A0EF-0ED591A94013Q33855041-6D032142-409A-4B1A-AA31-0F805D8BFE68Q33856474-3D57EBE5-C865-45EE-A683-230A70C5D9D2Q33887017-F26DF5F3-87DA-4127-A205-D4D2C2BDD9ABQ33887658-3FED0357-F5C4-4B86-A70C-8C30B9767877Q34044818-106F10FC-A228-4E70-A47A-ED25E410D946Q34533871-30F9A86E-3973-428B-BC1B-2F7663C97EE5Q34613520-1C3296F1-F209-4752-97C5-ACD45DC35B2FQ34686233-52E5A7D9-0738-4A09-ADA9-9F3DFC7DFF1AQ35000256-F252C912-52A7-492F-8670-142B11F3393CQ35017138-C3DCDC0E-6132-4684-8C4F-1AC3D67B5D7AQ35023795-C280E65C-F5FB-473C-A485-10B942EC6EC7Q35085998-AE9B94E3-31A6-450E-9F61-F53273410814Q35111420-B2D5882E-3F43-44F6-9E66-E2033B8CCE1DQ35505126-1F08C556-F9E9-408A-947F-EAAAC3C50B01Q35566484-54CB70DC-4FBB-4B32-AE5A-CCC12FD3ABD5Q35889261-2E6154D6-7165-42AD-AB8C-0295349F90C2Q35890322-D7EC6EAD-A8E7-48FF-A2B2-1B2E4B63DD88Q36072049-31DFE7CD-82DB-4DCA-AD11-838BC7E8D645Q36237801-9795466D-3B1B-4AC8-8E64-23884341FD16Q36540434-8A080DAC-85D7-409B-B44D-D36D29BFAAC2Q36544134-4ACEFDFF-1169-48B0-86F4-40487A0CE3C3Q36591484-FE81CD62-2D5F-4C1D-9031-720686F05EE6Q36661392-2035655F-23C5-4149-B7E1-3A9A366C08D3Q36679858-262CD488-46E6-4132-82D9-E8C436BC0E9EQ36737084-AB791133-F3A3-48E6-B6A4-020511A550F4Q36771879-753CE812-3546-4B47-87F7-0E7EBD9D1F2EQ36791997-71AD211E-5428-43D9-B638-8151F24ABE4AQ36833275-D30E6EE1-851C-4B3E-95BC-7803E33CFEAEQ37207675-9E3DC263-012A-40C0-A6D5-BBB0D0222D08Q37237114-6733A11D-30DF-4882-93CD-27CB3328D439Q37354086-8AA7E456-5ED5-41E0-A8EF-FF29B4A0CD86Q37461075-B805D307-70C6-4F08-82DA-E5E0997FBD59Q37588253-D903D63B-DC15-44A7-A7CF-00D5781C3104
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cancer stem cells in solid tumors: an overview.
@en
Cancer stem cells in solid tumors: an overview.
@nl
type
label
Cancer stem cells in solid tumors: an overview.
@en
Cancer stem cells in solid tumors: an overview.
@nl
prefLabel
Cancer stem cells in solid tumors: an overview.
@en
Cancer stem cells in solid tumors: an overview.
@nl
P1476
Cancer stem cells in solid tumors: an overview.
@en
P2093
Antonija Kreso
P356
10.1016/J.SEMRADONC.2008.11.001
P577
2009-04-01T00:00:00Z